|
시장보고서
상품코드
2089780
바이오의약품 포장 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 약물 유형별, 소재별, 지역별 및 부문별 예측(2026-2033년)Biopharmaceutical Packaging Market Size, Share & Trends Analysis Report By Product Type, By Drug Type, By Material, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
바이오의약품 포장 시장 개요
세계의 바이오의약품 포장 시장 규모는 2025년에 229억 달러로 추정되며, 2026년 248억 달러에서 2033년에는 454억 달러로 확대되어 2026년부터 2033년까지 CAGR은 9.0%에 달할 것으로 예측됩니다
2025년에는 북미가 39.8%로 전 세계 매출 점유율 1위를 차지했습니다. 바이오의약품, 백신, 바이오시밀러, 단일클론 항체, 세포 치료, 유전자 치료의 급속한 확산에 따라 전 세계 시장에서 바이오의약품 포장에 대한 수요가 급격히 증가하고 있습니다.
기존 의약품과 달리, 바이오의약품은 온도, 습도, 산소 노출, 오염 및 물리적 충격에 매우 민감합니다. 이러한 제품에는 보관, 운송, 투여의 전 과정에 걸쳐 무균성, 안정성 및 유효성을 유지할 수 있는 특수한 포장 솔루션이 필요합니다. 바이오의약품 기업들이 복잡한 주사제 및 맞춤형 치료제의 생산을 지속적으로 확대함에 따라, 프리필드 주사기, 바이알, 카트리지, 앰플, 보온 용기, 콜드체인 시스템 등 첨단 포장 형태에 대한 수요가 크게 증가하고 있습니다.
세포 치료 및 유전자 치료의 상용화가 진행됨에 따라, 포장 업계도 변화를 겪고 있습니다. 이러한 치료법은 그 가치가 매우 높을 뿐만 아니라 환자별로 맞춤화되어 있기 때문에 사소한 오염이나 온도 편차만으로도 막대한 경제적 손실이나 환자에게 심각한 위험을 초래할 가능성이 있습니다. 그 결과, 포장 제조업체들은 고도로 정교한 초저온 운송 용기, 진공 단열 용기, 상변화 소재, 위변조 방지 포장 및 스마트 모니터링 시스템을 개발하고 있습니다. 포장은 제품의 무결성을 유지할 뿐만 아니라, 공급망 전반에 걸친 추적 가능성과 규정 준수도 뒷받침해야 합니다. 많은 세포·유전자 치료에는 맞춤형 치료 과정이 수반되므로, 포장 솔루션 역시 기존의 의약품 포장 시스템보다 더욱 맞춤화되고, 확장성이 뛰어나며, 유연해야 합니다.
시장 성장을 뒷받침하는 또 다른 주요 요인은 전 세계적인 백신 접종 프로그램과 생물학적 제제의 유통망 확대입니다. COVID-19 유행 기간 동안 나타난 대규모 백신 운송 수요에 따라, 제약 회사와 의료 시스템은 콜드체인 인프라 및 단열 포장 기술에 대한 투자를 대폭 늘렸습니다. 현재 제약 업계에서는 포장을 단순한 운송 수단이 아닌, 제품의 안전성과 공급망의 신뢰성을 확보하기 위한 중요한 요소로 인식하고 있습니다. 이러한 변화로 인해 재사용 가능한 단열 포장재, 단열 운송 용기, 온도 표시기, 그리고 운송 중 실시간 모니터링을 가능하게 하는 IoT 기반 추적 시스템에 대한 수요가 증가하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 바이오의약품 포장 시장 : 변수, 동향, 범위
제4장 바이오의약품 포장 시장 : 소재별 추정·동향 분석
제5장 바이오의약품 포장 시장 : 약물 유형별 추정·동향 분석
제6장 바이오의약품 포장 시장 : 제품 유형별 추정·동향 분석
제7장 바이오의약품 포장 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSMBiopharmaceutical Packaging Market Summary
The global biopharmaceutical packaging market size was estimated at USD 22.9 billion in 2025 and is expected to grow from USD 24.8 billion in 2026 to USD 45.4 billion in 2033, at a CAGR of 9.0% from 2026 to 2033. North America held the largest global revenue share of 39.8% in 2025. The demand for biopharmaceutical packaging is growing rapidly across the global market due to the strong expansion of biologics, vaccines, biosimilars, monoclonal antibodies, cell therapies, and gene therapies.
Unlike conventional pharmaceutical drugs, biopharmaceutical products are highly sensitive to temperature, moisture, oxygen exposure, contamination, and physical shock. These products require specialized packaging solutions that can maintain sterility, stability, and efficacy throughout storage, transportation, and administration. As biopharmaceutical companies continue increasing production of complex injectable therapies and personalized medicines, the need for advanced packaging formats such as prefilled syringes, vials, cartridges, ampoules, insulated containers, and cold-chain systems is rising significantly.
The increasing commercialization of cell and gene therapies is also transforming the packaging industry. These therapies are extremely high-value and patient-specific, meaning any contamination or temperature deviation can result in major financial losses and serious patient risks. Consequently, packaging manufacturers are developing highly sophisticated cryogenic shippers, vacuum-insulated containers, phase-change materials, tamper-evident packaging, and smart monitoring systems. The packaging must not only preserve product integrity but also support traceability and regulatory compliance across the supply chain. Since many cell and gene therapies involve individualized treatment processes, packaging solutions must also become more customized, scalable, and flexible than traditional pharmaceutical packaging systems.
Another major factor fueling market growth is the expansion of global vaccination programs and biologic drug distribution networks. Following the large-scale vaccine transportation requirements seen during the COVID-19 period, pharmaceutical companies and healthcare systems significantly increased investments in cold-chain infrastructure and insulated packaging technologies. The pharmaceutical industry now recognizes packaging as a critical component of product safety and supply chain reliability rather than simply a transportation medium. This shift has increased demand for reusable thermal packaging, insulated shippers, temperature indicators, and IoT-enabled tracking systems that can provide real-time monitoring throughout transit.
Global Biopharmaceutical Packaging Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the biopharmaceutical packaging market report based on product type, material, drug type, and region:
- Product Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Pre-filled Syringes
- Vials & Ampoules
- Cartridges
- Bottles
- IV Bags & Containers
- Blister Packs
- Others
- Material Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Plastic Polymers
- Glass
- Others
- Drug Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Insulin
- Cell Therapies
- Gene Therapies
- Biosimilars
- Others
- Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Types & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Insights
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Biopharmaceutical Packaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Raw Material Trends
- 3.3.2. Technology/Manufacturing Trends
- 3.3.3. Sales Channel Analysis
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Industry Challenges
- 3.5.4. Industry Opportunities
- 3.6. Porter's Five Forces Analysis
- 3.6.1. Supplier Power
- 3.6.2. Buyer Power
- 3.6.3. Substitution Threat
- 3.6.4. Threat from New Entrants
- 3.6.5. Competitive Rivalry
- 3.7. PESTEL Analysis
- 3.7.1. Political Landscape
- 3.7.2. Economic Landscape
- 3.7.3. Social Landscape
- 3.7.4. Technological Landscape
- 3.7.5. Environmental Landscape
- 3.7.6. Legal Landscape
Chapter 4. Biopharmaceutical Packaging Market: Material Estimates & Trend Analysis
- 4.1. Definition & Scope
- 4.2. Key Takeaways
- 4.3. Material Movement Analysis & Market Share, 2025 & 2033
- 4.3.1. Plastic Polymers
- 4.3.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.3.2. Glass
- 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.3.3. Others
- 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.3.1. Plastic Polymers
Chapter 5. Biopharmaceutical Packaging Market: Drug Type Estimates & Trend Analysis
- 5.1. Definition & Scope
- 5.2. Key Takeaways
- 5.3. Drug Type Movement Analysis & Market Share, 2025 & 2033
- 5.3.1. Monoclonal Antibodies
- 5.3.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.2. Vaccines
- 5.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.3. Recombinant Proteins
- 5.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.4. Insulin
- 5.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.5. Cell Therapies
- 5.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.6. Gene Therapies
- 5.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.7. Biosimilars
- 5.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.8. Others
- 5.3.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.3.1. Monoclonal Antibodies
Chapter 6. Biopharmaceutical Packaging Market: Product Type Estimates & Trend Analysis
- 6.1. Definition & Scope
- 6.2. Key Takeaways
- 6.3. Product Type Movement Analysis & Market Share, 2025 & 2033
- 6.3.1. Pre-filled Syringes
- 6.3.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.2. Vials & Ampoules
- 6.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.3. Cartridges
- 6.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.4. Bottles
- 6.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.5. IV Bags & Containers
- 6.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.6. Blister Packs
- 6.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.7. Others
- 6.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.3.1. Pre-filled Syringes
Chapter 7. Biopharmaceutical Packaging Market: Regional Estimates & Trend Analysis
- 7.1. Key Takeaways
- 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.3.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.3.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.3.5. U.S.
- 7.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.3.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.3.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.3.5.5. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.6. Canada
- 7.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.3.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.3.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.3.6.5. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.7. Mexico
- 7.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.3.7.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.3.7.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.3.7.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.3.7.5. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.4.5. Germany
- 7.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.4.6. UK
- 7.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.4.7. France
- 7.4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.7.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.7.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.7.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.4.8. Italy
- 7.4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.8.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.8.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.8.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.4.9. Spain
- 7.4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.9.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.4.9.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.4.9.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5.5. China
- 7.5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5.6. India
- 7.5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5.7. Japan
- 7.5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.7.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.7.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.7.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5.8. South Korea
- 7.5.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.8.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.8.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.8.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.5.9. Australia
- 7.5.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.9.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.5.9.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.5.9.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.6.5. Brazil
- 7.6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.6.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.6.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.6.6. Argentina
- 7.6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.6.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.6.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.7. Middle East & Africa
- 7.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.7.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.7.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.7.5. Saudi Arabia
- 7.7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.5.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.7.5.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.7.5.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.7.6. South Africa
- 7.7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.6.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.7.6.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.7.6.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
- 7.7.7. UAE
- 7.7.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.7.2. Market Estimates and Forecasts, by Product Type, 2021 - 2033 (USD Million/Billion)
- 7.7.7.3. Market Estimates and Forecasts, by Material, 2021 - 2033 (USD Million/Billion)
- 7.7.7.4. Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million/Billion)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Market Positioning Analysis
- 8.4. Heat Map Analysis
- 8.5. Strategy Mapping
- 8.6. Company Profiles/Listing
- 8.6.1. Participant's Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.3.1. Gerresheimer
- 8.6.3.2. Multipharma
- 8.6.3.3. Bormioli Pharma
- 8.6.3.4. Merck KGaA
- 8.6.3.5. LOG Pharma Packaging
- 8.6.3.6. W.L. Gore & Associates, Inc.
- 8.6.3.7. West Pharmaceutical Services, Inc.
- 8.6.3.8. Pacific Vial Manufacturing
- 8.6.3.9. Piramal Glass Private Limited
- 8.6.3.10. Stevanato Group
- 8.6.3.11. Shandong Pharmaceutical Glass Co.
- 8.6.3.12. Chongqing Zhengchuan Pharmaceutical Packaging Co.
